Identification of an atypical interaction site in the BTB domain of the MYC-interacting zinc-finger protein 1
出版年份 2021 全文链接
标题
Identification of an atypical interaction site in the BTB domain of the MYC-interacting zinc-finger protein 1
作者
关键词
MIZ1, POZ domain, dimerization, homodimer, heterodimer, protein-protein interaction, transcription, HUWE1, X-ray crystallography, fluorescence polarization
出版物
STRUCTURE
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2021-06-28
DOI
10.1016/j.str.2021.06.005
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Achieving In Vivo Target Depletion through the Discovery and Optimization of Benzimidazolone BCL6 Degraders
- (2020) Benjamin R. Bellenie et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structural analysis of the PATZ1 BTB domain homodimer
- (2020) Sofia Piepoli et al. Acta Crystallographica Section D-Structural Biology
- Structural basis for dimerization quality control
- (2020) Elijah L. Mena et al. NATURE
- Small-molecule-induced polymerization triggers degradation of BCL6
- (2020) Mikołaj Słabicki et al. NATURE
- Deletion of the Miz-1 POZ domain increases efficacy of cytarabine treatment in T- and B-ALL/lymphoma mouse models
- (2019) Julie Ross et al. CANCER RESEARCH
- Identification of Thiourea-Based Inhibitors of the B-Cell Lymphoma 6 BTB Domain via NMR-Based Fragment Screening and Computer-Aided Drug Design
- (2018) Huimin Cheng et al. JOURNAL OF MEDICINAL CHEMISTRY
- Dimerization quality control ensures neuronal development and survival
- (2018) Elijah L. Mena et al. SCIENCE
- Development of a Novel B-Cell Lymphoma 6 (BCL6) PROTAC To Provide Insight into Small Molecule Targeting of BCL6
- (2018) William McCoull et al. ACS Chemical Biology
- An Open-Source, Cross-Platform Resource for Nonlinear Least-Squares Curve Fitting
- (2018) Andreas Möglich JOURNAL OF CHEMICAL EDUCATION
- Discovery of Pyrazolo[1,5-a]pyrimidine B-Cell Lymphoma 6 (BCL6) Binders and Optimization to High Affinity Macrocyclic Inhibitors
- (2017) William McCoull et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of a B-Cell Lymphoma 6 Protein–Protein Interaction Inhibitor by a Biophysics-Driven Fragment-Based Approach
- (2017) Yusuke Kamada et al. JOURNAL OF MEDICINAL CHEMISTRY
- 20 years of the SMART protein domain annotation resource
- (2017) Ivica Letunic et al. NUCLEIC ACIDS RESEARCH
- Chemically Induced Degradation of the Oncogenic Transcription Factor BCL6
- (2017) Nina Kerres et al. Cell Reports
- A conformational switch regulates the ubiquitin ligase HUWE1
- (2017) Bodo Sander et al. eLife
- P13, the EMBL macromolecular crystallography beamline at the low-emittance PETRA III ring for high- and low-energy phasing with variable beam focusing
- (2017) Michele Cianci et al. JOURNAL OF SYNCHROTRON RADIATION
- Broad-complex, tramtrack, and bric-à-brac (BTB) proteins: Critical regulators of development
- (2016) Edwin Chaharbakhshi et al. GENESIS
- Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphoma
- (2016) Mariano G. Cardenas et al. JOURNAL OF CLINICAL INVESTIGATION
- Nac1 interacts with the POZ-domain transcription factor, Miz1
- (2014) Mark A. Stead et al. BIOSCIENCE REPORTS
- Two ZNF509 (ZBTB49) isoforms induce cell-cycle arrest by activating transcription of p21/CDKN1A and RB upon exposure to genotoxic stress
- (2014) Bu-Nam Jeon et al. NUCLEIC ACIDS RESEARCH
- PhosphoSitePlus, 2014: mutations, PTMs and recalibrations
- (2014) Peter V. Hornbeck et al. NUCLEIC ACIDS RESEARCH
- The Ansamycin Antibiotic, Rifamycin SV, Inhibits BCL6 Transcriptional Repression and Forms a Complex with the BCL6-BTB/POZ Domain
- (2014) Sian E. Evans et al. PLoS One
- Structures of heterodimeric POZ domains of Miz1/BCL6 and Miz1/NAC1
- (2014) Mark Alexander Stead et al. Acta Crystallographica Section F-Structural Biology Communications
- Miz1 is required to maintain autophagic flux
- (2013) Elmar Wolf et al. Nature Communications
- High-Precision Isothermal Titration Calorimetry with Automated Peak-Shape Analysis
- (2012) Sandro Keller et al. ANALYTICAL CHEMISTRY
- The crystal structure of the catalytic domain of a eukaryotic guanylate cyclase
- (2012) Jonathan A Winger et al. BMC STRUCTURAL BIOLOGY
- Overview of theCCP4 suite and current developments
- (2011) Martyn D. Winn et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- The Mechanism of Linkage-Specific Ubiquitin Chain Elongation by a Single-Subunit E2
- (2011) Katherine E. Wickliffe et al. CELL
- The proto-oncoprotein KR-POK represses transcriptional activation of CDKN1A by MIZ-1 through competitive binding
- (2011) K M Lee et al. ONCOGENE
- XDS
- (2010) Wolfgang Kabsch ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- PHENIX: a comprehensive Python-based system for macromolecular structure solution
- (2010) Paul D. Adams et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- A Small-Molecule Inhibitor of BCL6 Kills DLBCL Cells In Vitro and In Vivo
- (2010) Leandro C. Cerchietti et al. CANCER CELL
- Transcription Factor Miz-1 Is Required to Regulate Interleukin-7 Receptor Signaling at Early Commitment Stages of B Cell Differentiation
- (2010) Christian Kosan et al. IMMUNITY
- Insights into Strand Exchange in BTB Domain Dimers from the Crystal Structures of FAZF and Miz1
- (2010) Peter J. Stogios et al. JOURNAL OF MOLECULAR BIOLOGY
- Structures of SPOP-Substrate Complexes: Insights into Molecular Architectures of BTB-Cul3 Ubiquitin Ligases
- (2009) Min Zhuang et al. MOLECULAR CELL
- A peptomimetic inhibitor of BCL6 with potent antilymphoma effects in vitro and in vivo
- (2008) L. C. Cerchietti et al. BLOOD
- Zbtb4 represses transcription of P21CIP1 and controls the cellular response to p53 activation
- (2008) Axel Weber et al. EMBO JOURNAL
- Structure of a BCOR Corepressor Peptide in Complex with the BCL6 BTB Domain Dimer
- (2008) Alexandru F. Ghetu et al. MOLECULAR CELL
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started